Keros Therapeutics, Inc.
KROS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001664710
In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Keros Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 147
- +27 vs. Q4 2023
- Shares held
- 31.4M
- +5.66M (+22.0%) vs. Q4 2023
- Total value
- $2.08B
- +$1.05B (+103.0%) vs. Q4 2023
- New holders
- 37
- 57 more added
- Sold out
- 10
- 40 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KROS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 132 | $198.6M |
| Q1 2026 | 151 | $205.6M |
| Q4 2025 | 166 | $408.4M |
| Q3 2025 | 155 | $558.0M |
| Q2 2025 | 139 | $479.6M |
| Q1 2025 | 156 | $428.6M |
| Q4 2024 | 161 | $582.1M |
| Q3 2024 | 164 | $2.03B |
| Q2 2024 | 152 | $1.44B |
| Q1 2024 | 147 | $2.08B |
| Q4 2023 | 121 | $1.02B |
| Q3 2023 | 107 | $730.6M |
| Q2 2023 | 123 | $901.0M |
| Q1 2023 | 129 | $937.0M |
| Q4 2022 | 126 | $948.2M |
| Q3 2022 | 113 | $680.1M |
| Q2 2022 | 104 | $479.7M |
| Q1 2022 | 106 | $893.0M |
| Q4 2021 | 99 | $944.5M |
| Q3 2021 | 89 | $545.4M |
| Q2 2021 | 80 | $599.7M |
| Q1 2021 | 83 | $887.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Keros Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | 99,633 | $6.60M | 0.00% | +5,129+5.4% | Added |
| Nuveen Asset Management, LLC | 101,239 | $6.70M | 0.00% | +25,643+33.9% | Added |
| WCM Investment Management, LLC | 117,030 | $7.75M | 0.02% | −37,634−24.3% | Reduced |
| Citigroup Inc | 117,456 | $7.78M | 0.01% | −51,935−30.7% | Reduced |
| Rafferty Asset Management, LLC | 119,511 | $7.91M | 0.03% | +54,230+83.1% | Added |
| Deutsche Bank AG | 124,072 | $8.21M | 0.00% | −234,204−65.4% | Reduced |
| UBS Group AG | 124,185 | $8.22M | 0.00% | −57,200−31.5% | Reduced |
| Granahan Investment Management Inc | 149,013 | $9.86M | 0.35% | +149,013 | New |
| Dimensional Fund Advisors LP | 165,406 | $10.9M | 0.00% | −5,446−3.2% | Reduced |
| Bank of America Corp | 172,477 | $11.4M | 0.00% | −20,972−10.8% | Reduced |
| Blue Owl Capital Holdings LP | 172,633 | $11.4M | 2.28% | −180,000−51.0% | Reduced |
| Parkman Healthcare Partners LLC | 178,335 | $11.8M | 1.45% | −182,132−50.5% | Reduced |
| EcoR1 Capital, LLC | 187,500 | $12.4M | 0.32% | +187,500 | New |
| Adage Capital Partners GP, L.L.C. | 190,000 | $12.6M | 0.02% | +190,000 | New |
| CIBC World Markets Corp | 200,000 | $13.2M | 0.09% | +200,000 | New |
| Charles Schwab Investment Management Inc | 207,758 | $13.8M | 0.00% | +26,180+14.4% | Added |
| Avidity Partners Management LP | 209,700 | $13.9M | 0.49% | +209,700 | New |
| Northern Trust Corp | 235,638 | $15.6M | 0.00% | +18,792+8.7% | Added |
| American Century Companies Inc | 238,806 | $15.8M | 0.01% | +24,209+11.3% | Added |
| Goldman Sachs Group Inc | 258,368 | $17.1M | 0.00% | +53,269+26.0% | Added |
| Marshall Wace, LLP | 272,971 | $18.1M | 0.03% | +223,499+451.8% | Added |
| Soleus Capital Management, L.P. | 273,600 | $18.1M | 1.59% | +273,600 | New |
| Morgan Stanley | 289,157 | $19.1M | 0.00% | −636,231−68.8% | Reduced |
| Nantahala Capital Management, LLC | 293,997 | $19.5M | 1.91% | −16,144−5.2% | Reduced |
| Millennium Management LLC | 337,663 | $22.4M | 0.02% | −184,465−35.3% | Reduced |
| ADAR1 Capital Management, LLC | 338,243 | $22.4M | 6.11% | −350,073−50.9% | Reduced |
| Opaleye Management Inc. | 367,500 | $24.3M | 5.30% | +10,000+2.8% | Added |
| Citadel Advisors LLC | 450,278 | $29.8M | 0.03% | −309,890−40.8% | Reduced |
| Redmile Group, LLC | 552,506 | $36.6M | 1.34% | +552,506 | New |
| Geode Capital Management, LLC | 595,846 | $39.5M | 0.00% | +85,635+16.8% | Added |
| Franklin Resources Inc | 632,049 | $41.8M | 0.01% | −67,376−9.6% | Reduced |
| Jefferies Financial Group Inc. | 633,671 | $41.9M | 0.85% | +617,771+3,885.4% | Added |
| Holocene Advisors, LP | 637,983 | $42.2M | 0.16% | +637,983 | New |
| Candriam Luxembourg S.C.A. | 651,999 | $43.2M | 0.28% | −167,063−20.4% | Reduced |
| Eventide Asset Management, LLC | 680,000 | $45.0M | 0.71% | +100,000+17.2% | Added |
| Braidwell LP | 737,379 | $48.8M | 1.57% | −381,582−34.1% | Reduced |
| Woodline Partners LP | 761,700 | $50.4M | 0.47% | +177,908+30.5% | Added |
| TCG Crossover Management, LLC | 879,344 | $58.2M | 4.60% | +879,344 | New |
| Point72 Asset Management, L.P. | 971,881 | $64.3M | 0.19% | +890,651+1,096.5% | Added |
| Price T Rowe Associates Inc | 1,218,504 | $80.7M | 0.01% | +176,803+17.0% | Added |
| OrbiMed Advisors LLC | 1,268,734 | $84.0M | 1.64% | 00.0% | Unchanged |
| Darwin Global Management, Ltd. | 1,435,950 | $95.1M | 12.65% | +375,523+35.4% | Added |
| Vanguard Group Inc | 1,545,758 | $102.3M | 0.00% | +113,563+7.9% | Added |
| State Street Corp | 1,562,895 | $103.5M | 0.00% | +508,528+48.2% | Added |
| Alkeon Capital Management LLC | 1,598,907 | $105.8M | 0.58% | +100,000+6.7% | Added |
| BlackRock Inc. | 2,166,010 | $143.4M | 0.00% | +129,222+6.3% | Added |
| FMR LLC | 5,018,516 | $332.2M | 0.02% | +1,144,312+29.5% | Added |
| Norges Bank | 0 | $0 | 0.00% | −35,700−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,122−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −12,252−100.0% | Sold out |
| Chescapmanager LLC | 0 | $0 | 0.00% | −10,105−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −5,802−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −5,205−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −969−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −411−100.0% | Sold out |
| BFSG, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |